1. Home
  2. PPSI vs SCYX Comparison

PPSI vs SCYX Comparison

Compare PPSI & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPSI
  • SCYX
  • Stock Information
  • Founded
  • PPSI 2008
  • SCYX 1999
  • Country
  • PPSI United States
  • SCYX United States
  • Employees
  • PPSI N/A
  • SCYX N/A
  • Industry
  • PPSI Electrical Products
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PPSI Industrials
  • SCYX Health Care
  • Exchange
  • PPSI Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • PPSI 30.0M
  • SCYX 28.5M
  • IPO Year
  • PPSI N/A
  • SCYX 2014
  • Fundamental
  • Price
  • PPSI $2.76
  • SCYX $0.71
  • Analyst Decision
  • PPSI Strong Buy
  • SCYX
  • Analyst Count
  • PPSI 1
  • SCYX 0
  • Target Price
  • PPSI $12.00
  • SCYX N/A
  • AVG Volume (30 Days)
  • PPSI 38.7K
  • SCYX 145.5K
  • Earning Date
  • PPSI 09-09-2025
  • SCYX 08-07-2025
  • Dividend Yield
  • PPSI 54.55%
  • SCYX N/A
  • EPS Growth
  • PPSI N/A
  • SCYX N/A
  • EPS
  • PPSI 2.84
  • SCYX N/A
  • Revenue
  • PPSI $26,304,000.00
  • SCYX $2,630,000.00
  • Revenue This Year
  • PPSI $24.01
  • SCYX $463.61
  • Revenue Next Year
  • PPSI $19.25
  • SCYX $310.80
  • P/E Ratio
  • PPSI $0.96
  • SCYX N/A
  • Revenue Growth
  • PPSI 439.46
  • SCYX N/A
  • 52 Week Low
  • PPSI $2.25
  • SCYX $0.66
  • 52 Week High
  • PPSI $7.00
  • SCYX $2.29
  • Technical
  • Relative Strength Index (RSI)
  • PPSI 54.00
  • SCYX 38.69
  • Support Level
  • PPSI $2.65
  • SCYX $0.67
  • Resistance Level
  • PPSI $2.76
  • SCYX $0.75
  • Average True Range (ATR)
  • PPSI 0.10
  • SCYX 0.04
  • MACD
  • PPSI 0.00
  • SCYX 0.00
  • Stochastic Oscillator
  • PPSI 79.31
  • SCYX 33.06

About PPSI Pioneer Power Solutions Inc.

Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: